Arbutus Biopharma Corp (ABUS) — Financial Flexibility Index
Arbutus Biopharma Corp (ABUS) has a Financial Flexibility Index of -0.48x as of March 2026. Free cash flow of $-8.11 Million (operating CF $-8.11 Million minus capex $0.00) represents 0% of total liabilities ($16.99 Million). Check ABUS strategic asset allocation to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Arbutus Biopharma Corp Financial Flexibility Index (1998–2025)
Historical Financial Flexibility Index trend for Arbutus Biopharma Corp across 28 annual periods. See ABUS net working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Arbutus Biopharma Corp (1998–2025)
Year-by-year free cash flow to debt coverage for Arbutus Biopharma Corp. For the full company profile including market capitalisation, see Arbutus Biopharma Corp market cap and net worth.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -2.20x | $-39.64 Million | $-39.64 Million | $18.04 Million | ▼ -16.7% |
| 2024 | -1.88x | $-64.67 Million | $-64.85 Million | $34.34 Million | ▲ +14.9% |
| 2023 | -2.21x | $-84.93 Million | $-85.94 Million | $38.38 Million | ▼ -271.9% |
| 2022 | -0.59x | $-34.84 Million | $-35.36 Million | $58.57 Million | ▲ +68.8% |
| 2021 | -1.90x | $-66.72 Million | $-67.53 Million | $35.05 Million | ▼ -30.5% |
| 2020 | -1.46x | $-51.21 Million | $-51.44 Million | $35.11 Million | ▲ +32.1% |
| 2019 | -2.15x | $-70.42 Million | $-71.01 Million | $32.79 Million | ▲ +11.0% |
| 2018 | -2.41x | $-66.76 Million | $-67.90 Million | $27.67 Million | ▼ -219.3% |
| 2017 | -0.76x | $-41.34 Million | $-48.60 Million | $54.70 Million | ▼ -2.2% |
| 2016 | -0.74x | $-53.89 Million | $-57.88 Million | $72.90 Million | ▼ -131.8% |
| 2015 | -0.32x | $-52.50 Million | $-54.78 Million | $164.61 Million | ▲ +15.3% |
| 2014 | -0.38x | $-11.37 Million | $-12.42 Million | $30.20 Million | ▲ +21.6% |
| 2013 | -0.48x | $-6.01 Million | $-6.74 Million | $12.52 Million | ▼ -116.8% |
| 2012 | 2.85x | $33.29 Million | $33.27 Million | $11.68 Million | ▲ +424.6% |
| 2011 | -0.88x | $-7.46 Million | $-7.52 Million | $8.50 Million | ▲ +13.3% |
| 2010 | -1.01x | $-10.42 Million | $-11.25 Million | $10.29 Million | ▼ -82.3% |
| 2009 | -0.56x | $-3.62 Million | $-5.24 Million | $6.51 Million | ▲ +70.1% |
| 2008 | -1.85x | $-7.52 Million | $-8.48 Million | $4.05 Million | ▼ -784.4% |
| 2007 | -0.21x | $-1.36 Million | $-2.72 Million | $6.46 Million | ▲ +51.2% |
| 2006 | -0.43x | $-2.53 Million | $-2.62 Million | $5.88 Million | ▼ -9.5% |
| 2005 | -0.39x | $-14.53 Million | $-14.57 Million | $36.99 Million | ▼ -615.2% |
| 2004 | -0.05x | $-2.83 Million | $-9.98 Million | $51.60 Million | ▲ +98.5% |
| 2003 | -3.56x | $-26.18 Million | $-26.96 Million | $7.35 Million | ▼ -73.0% |
| 2002 | -2.06x | $-16.21 Million | $-18.16 Million | $7.87 Million | ▼ -39.1% |
| 2001 | -1.48x | $-9.06 Million | $-10.00 Million | $6.12 Million | ▲ +54.7% |
| 2000 | -3.27x | $-8.15 Million | $-8.35 Million | $2.49 Million | ▲ +4.0% |
| 1999 | -3.40x | $-6.54 Million | $-6.84 Million | $1.92 Million | ▼ -6.6% |
| 1998 | -3.19x | $-4.49 Million | $-7.71 Million | $1.40 Million | — |